25 research outputs found

    Accelerated Aggregation Studies of Monoclonal Antibodies: Considerations for Storage Stability

    No full text
    Aggregation of mAbs is a crucial concern with respect to their safety and efficacy. Among the various properties of protein aggregates, it is emerging that their size can potentially impact their immunogenicity. Therefore, stability studies of antibody formulations should not only evaluate the rate of monomer loss but also determine the size distribution of the protein aggregates, which in turn depends on the aggregation mechanism. Here, we study the aggregation behavior of different formulations of 2 monoclonal immunoglobulins (IgGs) in the temperature range from 5 C to 50 C over 52 weeks of storage. We show that the aggregation kinetics of both antibodies follow non-Arrhenius behavior and that the aggregation mechanisms change between 40 C and 5 C, leading to different types of aggregates. Specifically, for a given monomer conversion, dimer formation dominates at low temperatures, while larger aggregates are formed at higher temperatures. We further show that the stability ranking of different molecules as well as of different formulations is drastically different at 40 C and 5 C while it correlates better between 30 C and 5 C. Our findings have implications for the level of information provided by accelerated aggregation studies with respect to protein stability under storage conditionsstatus: Published onlin

    Excipient screening for spray drying of monoclonal antibodies

    No full text
    PURPOSE Spray drying (SD) was selected for converting monoclonal antibody (mAb) solutions into powders for reconstitution, which could increase mAb (storage) stability. The technique is able to yield readily dispersible powders, but addition of excipients is required to stabilise the mAbs during drying and subsequent storage 1, 2. Therefore, a large scale excipient screening was conducted to assess the impact of sugars, surfactant and amino acids (AAs) on mAb stability. METHODS mAB formulations were spray dried using a Büchi B-290 Mini Spray dryer, equipped with a two-fluid nozzle (0.7 mm internal diameter). Feed solutions contained the model mAb at a concentration of 50 mg/mL. For analysis, spray dried mAb powders were reconstituted to 100 mg/mL solutions. Moisture content was analysed using a Metrohm Titrino 831 Coulometer. Aggregation was assessed using a size exclusion chromatography (Tososh TSKgel G3000SWxl column) combined with multi-angle light scattering analysis (Wyatt miniDAWN TREOS), dynamic light scattering (Wyatt Möbius) and image analysis (Occhio ipac). RESULTS Addition of a non-ionic surfactant (polysorbate 20) to the formulation maintained the model mAb's physical integrity during the SD process. Formulations containing a single AA, a combination of two AAs or their respective salts, were unable to adequately stabilise the mAb during 4 weeks of storage at 40°C, although basic AAs were found to stabilise the mAb to a greater extent than other tested AAs. Stability was further improved by combining these AAs with a disaccharide, where the combination of L-lysineHCl, trehalose and polysorbate 20 was found to stabilise the model mAb to a greater extent than the other formulations. CONCLUSION Formulations containing a basic AA, a disaccharide and a surfactant were found to have superior mAb stabilising properties compared to other tested formulations. However, further formulation optimisation is deemed necessary, as well as investigating interactions between excipients and identifying process parameters impacting mAb stability. REFERENCES 1. C. J. Roberts, Protein aggregation and its impact on product quality, Curr. Opin. Biotechnol.. 30 (2014) 211 - 217. 2. A. Ajmera, R. Scherließ, Stabilisation of proteins via mixtures of amino acids during spray drying, Int. J. Pharm. 463 (1) (2014) 98 - 107.status: publishe

    Crystallization and preliminary X-ray diffraction analysis of the arginine repressor of the hyperthermophile Thermotoga neapolitana

    No full text
    The arginine repressor of the hyperthermophile T. neapolitana was crystallized with and without its corepressor arginine. Both crystals diffracted to high resolution and belong to the orthorhombic space group P212121, with similar unit-cell parameters

    Excipient screening for spray drying of monoclonal antibodies

    No full text
    INTRODUCTION & GOALS Spray drying (SD) was selected for converting monoclonal antibody (mAb) solutions into powders for reconstitution, which could increase mAb (storage) stability. The technique is able to yield readily dispersible powders, but addition of excipients is required to stabilise the mAbs during drying and subsequent storage 1, 2. Therefore, a large scale excipient screening was conducted to assess the impact of sugars, surfactant and amino acids (AAs) on mAb stability. METHODS mAB formulations were spray dried using a Büchi B-290 Mini Spray dryer, equipped with a two-fluid nozzle (0.7 mm internal diameter). Feed solutions contained the model mAb at a concentration of 50 mg/mL. For analysis, spray dried mAb powders were reconstituted to 100 mg/mL solutions. Moisture content was analysed using a Metrohm Titrino 831 Coulometer. Aggregation was assessed using a size exclusion chromatography (Tososh TSKgel G3000SWxl column) combined with multi-angle light scattering analysis (Wyatt miniDAWN TREOS), dynamic light scattering (Wyatt Möbius) and image analysis (Occhio ipac). RESULTS & DISCUSSION Addition of a non-ionic surfactant (polysorbate 20) to the formulation maintained the model mAb’s physical integrity during the SD process. Formulations containing a single AA, a combination of two AAs or their respective salts, were unable to adequately stabilise the mAb during 4 weeks of storage at 40°C, although basic AAs were found to stabilise the mAb to a greater extent than other tested AAs. Stability was further improved by combining these AAs with a disaccharide. CONCLUSION Formulations containing a basic AA, a disaccharide and a surfactant were found to have superior mAb stabilising properties compared to other tested formulations. However, further formulation optimisation is deemed necessary, as well as investigating interactions between excipients and identifying process parameters impacting mAb stability. REFERENCES 1. C. J. Roberts, Protein aggregation and its impact on product quality, Curr. Opin. Biotechnol.. 30 (2014) 211 – 217. 2. A. Ajmera, R. Scherließ, Stabilisation of proteins via mixtures of amino acids during spray drying, Int. J. Pharm. 463 (1) (2014) 98 – 107.status: publishe
    corecore